A review of human coronaviruses’ receptors: the host-cell targets for the crown bearing viruses A Nassar, IM Ibrahim, FG Amin, M Magdy, AM Elgharib, EB Azzam, ... Molecules 26 (21), 6455, 2021 | 51 | 2021 |
In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease I Khater, A Nassar Biochemistry and Biophysics Reports 27, 101032, 2021 | 29 | 2021 |
Potential antiviral peptides targeting the SARS-CoV-2 spike protein I Khater, A Nassar BMC Pharmacology and Toxicology 23 (1), 91, 2022 | 7 | 2022 |
Repurposing antiviral drugs to inhibit SARS-CoV-2 Papin-like protease activity I Khater, A Nassar International Journal of Intelligent Computing and Information Sciences 21 …, 2021 | 2 | 2021 |
In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoids FG Amin, AA Elfiky, AM Nassar Journal of Biomolecular Structure and Dynamics 42 (2), 1079-1087, 2024 | 1 | 2024 |
A computational peptide model induces cancer cells’ apoptosis by docking Kringle 5 to GRP78 I Khater, A Nassar BMC molecular and cell biology 24 (1), 25, 2023 | 1 | 2023 |
Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis I Khater, A Nassar Plos one 17 (5), e0268909, 2022 | 1 | 2022 |
Looking into mucormycosis coinfections in COVID-19 patients using computational analysis. I Khater, A Nassar AIMS Biophysics 9 (1), 2022 | 1 | 2022 |
SARS-CoV-2 variant surge and vaccine breakthrough infection: a computational analysis I Khater, A Nassar Informatics in medicine unlocked 29, 100873, 2022 | 1 | 2022 |
Targeting EGFR and VEGFR-2 Kinases With Nanoparticles: A Computational Approach for Cancer Therapy Advancement I Khater, A Nassar Cancer Investigation 42 (2), 176-185, 2024 | | 2024 |
Potent Inhibitors for SARS-COV-2 Main Protease: An in-Silico Study for Drug Development I Khater, A Nassar Authorea Preprints, 2020 | | 2020 |